Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome. - Suppr | 超能文献

Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome.

作者信息

Kashiwagi Yasuyo, Kawashima Hisashi, Nishimata Shigeo, Nagao Ryuhei, Watanabe Kiyoko, Takekuma Kouji, Hoshika Akinori

机构信息

Department of Pediatrics, Tokyo Medical University, Tokyo, Japan.

出版信息

Clin Rheumatol. 2008 Feb;27(2):277-9. doi: 10.1007/s10067-007-0734-7. Epub 2007 Sep 22.

DOI:10.1007/s10067-007-0734-7

Abstract

We describe a case of severe CINCA syndrome in a Japanese male infant. We recently managed with anti-interleukin 1 agent (anakinra). Anakinra immediately led to improvement of both the clinical symptoms and the laboratory findings.

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome.

Clin Rheumatol. 2008 Feb;27(2):277-9. doi: 10.1007/s10067-007-0734-7. Epub 2007 Sep 22.

2

Cochlear implantation in a child with CINCA syndrome who also has wide vestibular aqueducts.

Cochlear Implants Int. 2012 Aug;13(3):173-6. doi: 10.1179/1754762811Y.0000000005. Epub 2011 Jun 29.

3

A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents.

Arthritis Rheum. 2006 Jul;54(7):2314-20. doi: 10.1002/art.21965.

4

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

Arthritis Rheum. 2010 Jan;62(1):258-67. doi: 10.1002/art.25057.

5

Neonatal treatment of CINCA syndrome.

Pediatr Rheumatol Online J. 2014 Dec 15;12:52. doi: 10.1186/1546-0096-12-52. eCollection 2014.

6

Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature.

Scand J Rheumatol. 2011 Jan;40(1):74-9. doi: 10.3109/03009742.2010.493894. Epub 2010 Oct 11.

7

Long-Term Efficacy of Anakinra in Cryopyrin-Associated Periodic Syndrome: Focus on Destructive Arthropathy.

J Clin Immunol. 2021 Nov;41(8):1936-1939. doi: 10.1007/s10875-021-01099-z. Epub 2021 Aug 4.

8

Anakinra in mutation-negative CINCA syndrome.

Clin Rheumatol. 2007 Apr;26(4):576-7. doi: 10.1007/s10067-005-0168-z. Epub 2006 Jan 27.

9

Hydrocephalus in CINCA syndrome treated with anakinra.

Childs Nerv Syst. 2006 Apr;22(4):334-7. doi: 10.1007/s00381-006-1280-3. Epub 2006 Mar 9.

10

[Evaluation of 2-year treatment of Schnitzler syndrome (urticarial exanthema, monoclonal IgM gammopathy and osteolytic-osteosclerotic skeletal changes) using Anakinra (Kineret)].

Vnitr Lek. 2009 Dec;55(12):1196-7.

引用本文的文献

1

A Novel Mutation in the NBD Domain of Causes Mild Autoinflammation With Recurrent Urticaria.

Front Immunol. 2021 Jun 23;12:674808. doi: 10.3389/fimmu.2021.674808. eCollection 2021.

2

[IL-1 antagonists].

Z Rheumatol. 2010 Sep;69(7):581-93. doi: 10.1007/s00393-009-0530-7.

本文引用的文献

1

A case report of neonatal onset multisystemic inflammatory disease in Japan treated with continuous hemodiafiltration and steroid pulse therapy.

Ther Apher Dial. 2007 Jun;11(3):232-4. doi: 10.1111/j.1744-9987.2007.00465.x.

2

A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents.

Arthritis Rheum. 2006 Jul;54(7):2314-20. doi: 10.1002/art.21965.

3

Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene.

Acta Paediatr. 2006 Feb;95(2):246-9. doi: 10.1080/08035250500341451.

4

Anakinra in mutation-negative CINCA syndrome.

Clin Rheumatol. 2007 Apr;26(4):576-7. doi: 10.1007/s10067-005-0168-z. Epub 2006 Jan 27.

5

Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS).

Rheumatology (Oxford). 2005 Aug;44(8):1072-3. doi: 10.1093/rheumatology/keh652. Epub 2005 Apr 19.

6

Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease.

Arthritis Rheum. 2005 Apr;52(4):1283-6. doi: 10.1002/art.20953.

7

Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome.

Rheumatology (Oxford). 2005 May;44(5):689-90. doi: 10.1093/rheumatology/keh547. Epub 2005 Jan 25.

8

Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al and Hoffman and Patel.

Arthritis Rheum. 2004 Nov;50(11):3738-9; author reply 3739-40. doi: 10.1002/art.20497.

9

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.

Arthritis Rheum. 2004 Feb;50(2):607-12. doi: 10.1002/art.20033.

10

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

Arthritis Rheum. 2002 Dec;46(12):3340-8. doi: 10.1002/art.10688.